Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

Bristol Myers Squibb is the latest pharma company to sue the federal government over its rejection of a proposed new model ...

The federal 340B Drug Pricing Program — a noble idea first enacted in 1992 — needs to be brought back into the shop for ...

The 340B program's “covered entities” serve low-income, poorer populations that tend to be un- or underinsured. Many, if not ...

Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

Bristol Myers Squibb Co. is challenging a federal health agency for denying its plan to implement a rebate model for its ...

Proposition 34 confronts the longtime abuse of the federal 340B prescription drug program and will hold bad actors ...

Canberra-based Link Airways and Canberra Airport have announced direct flights between Canberra and Coffs Harbour will ...

Proposition 33, which would have repealed California’s Costa-Hawkins Act, a law that limits local governments’ authority over ...

RFK Jr. has focused attention on the pharma industry, but hospitals are more at risk from the Republican party’s agenda.

Advanz Pharma's liver treatment Ocaliva lost EU marketing authorization following a court decision. The drug, used for ...